Ignite Creation Date:
2025-12-24 @ 7:33 PM
Ignite Modification Date:
2026-03-05 @ 3:30 AM
Study NCT ID:
NCT02145403
Status:
COMPLETED
Last Update Posted:
2022-01-03
First Post:
2014-05-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
Sponsor:
Organization: